2020-2025 Florida Cancer Plan Proposed Revisions
The Florida Cancer Control and Research Advisory Council (CCRAB) is considering several revisions to the Florida Cancer Plan. These proposed revisions were presented and discussed during the CCRAB meeting on October 23, 2020.
The 30-day consideration period for CCRAB Council Members to provide comments and approval will begin on Monday, November 16, 2020. Comments must be submitted to Bobbie.Mc[email protected] by 5:00 PM (ET) on Wednesday, December 16, 2020.
Proposed revisions change baselines for objectives 9.1, 9.2 and 9.4 based on new data; updates annual percentage increases for each objective based on the new baseline data.
Objective 9.1: By 2025, increase the annual number of homes measured for radon from
11,570 16,940 to 14,080 25,420 homes (increase by 4 7% annually).
Objective 9.2: By 2025, increase the annual number of homes mitigated for radon from
1,190 1,950 to 1,440 2,600 homes (increase by 4 5% annually).
Objective 9.4: By 2025, increase the number of Florida real estate transactions that include radon testing from
6,500 8,080 to 7,500 10,220 in five years (increase by 3 4% annually).
Prostate Cancer Goal:
Proposed revision rationale: Advanced disease implies disease extension either regionally to lymph nodes or distant metastases to bone. Options for treatment are palliative for metastatic or advanced disease. Aggressive disease (Gleason 7 or greater) more appropriately describes contained, high-risk, but treatable and potentially curable disease if diagnosed early through proper screening. Sophisticated supplemental PSA testing including serum 4K is an algorithm calculating risk for “aggressive” disease and is used to additionally guide the prostate biopsy decision.
Goal 13: Reduce prostate cancer mortality in Florida men
through early detection of advanced disease at high risk for aggressive prostate cancer through screening and early detection.
Hepatitis C Virus (HCV) Goal/Objective:
Proposed revision changes age range to match U.S. Preventive Services Task Force (USPSTF) recommendation update.
Objective 14.1: By 2025, identify or develop a surveillance method that measures the percentage of Floridians
born between 1945 and 1965 aged 18 to 79 years old who were offered and received HCV testing.